Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2003 May 13;88(10):1622–1630. doi: 10.1038/sj.bjc.6600911

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2003 Cancer Research UK

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Cytotoxicity studies. (A) Sensitivity of HU-V-EC (○) and SK-OV-3 cells (•) to treatment with the prodrug CMDA. Arrowheads show the maximum concentrations of CMDA that the HU-V-EC (▿) and SK-OV-3 cells (▾) cells can tolerate without measurable cell death. (B) Effect on the survival of HU-V-EC cells of preincubation with CPG2(Q)3-H₆, CPG2(Q)3-VEGF109-H₆, or VEGF115CPG2(Q)3-H₆, at doses of 0.5 nm (plain bars), 5 nm (shaded bars), or 50 nm (filled bars) and subsequent treatment with 500 μM CMDA. (C) Sensitivity of HU-V-EC and SK-OV-3 cells to CMDA challenge (500 and 1000 μM, respectively) after a 30 min incubation with 50 nm VEGF₁₁₅CPG2(Q)3-H₆.